IPCA Laboratories share price
You have to be logged in to add this to Watchlist.- ₹1,570.00(-1.00%)June 15, 2026 15:29:45 PM IST
- NSE
- BSE
- Vol : 165.92 K (NSE + BSE)Last 20 day avg : 347.44 K
IPCA Laboratories is trading -1.00% lower at Rs 1,570.00 as compared to its last closing price. IPCA Laboratories has been trading in the price range of 1,615.95 & 1,565.95. IPCA Laboratories has given 11.57% in this year & -3.59% in the last 5 days. IPCA Laboratories has TTM P/E ratio 35.60 as compared to the sector P/E of 26.98.There are 14 analysts who have initiated coverage on IPCA Laboratories. There are 7 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 299.07 Crores in its last quarter.Listed peers of IPCA Laboratories include Sun Pharmaceutical Industries (-0.40%), Torrent Pharmaceuticals (-1.44%), Divi's Laboratories (-0.38%).The Mutual Fund holding in IPCA Laboratories was at 31.24% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in IPCA Laboratories was at 10.63% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jun 15, 2026, 11:10 PM UTC
- BetaLow volatility0.45Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.10The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.38Annual dividends as a percentage of the stock price.
- PEG RatioIndicates Fair Valuation1.03The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,800.00 | -0.40 | 4,31,870.12 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,508.95 | -1.44 | 1,52,528.87 | 67.32 | 17.1 | 0.83 | 17.62 |
| Divi's Laboratories | Bullish | 6,608.15 | -0.38 | 1,75,538.10 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,280.00 | 0.48 | 1,06,839.48 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Neutral | 1,382.00 | -0.49 | 1,11,638.04 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-29 | Audited Results & Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE571A01038
- BSE Code524494
- NSE CodeIPCALAB
IPCA Laboratories is trading at 1570.00 as on Mon Jun 15 2026 09:59:45. This is -1.00% lower as compared to its previous closing price of 1585.80.
The market capitalization of IPCA Laboratories is 39694.34 Cr as on Mon Jun 15 2026 09:59:45.
The average broker rating on IPCA Laboratories is Strong Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 2 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for IPCA Laboratories is 1679.45 whereas the 52 wk low is 1252.95
IPCA Laboratories can be analyzed on the following key metrics -
- TTM P/E: 35.60
- Sector P/E: 26.98
- Dividend Yield: 0.38%
- D/E ratio: 0.10
IPCA Laboratories reported a net profit of 1141.12 Cr in 2026.
The Mutual Fund Shareholding was 31.24% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
IPCA Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.